Norinchukin Bank The bought a new position in Iqvia Holdings Inc (NYSE:IQV) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 17,711 shares of the medical research company’s stock, valued at approximately $1,734,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Winslow Evans & Crocker Inc. acquired a new stake in shares of Iqvia in the fourth quarter worth approximately $123,000. Valeo Financial Advisors LLC acquired a new position in Iqvia during the fourth quarter valued at approximately $170,000. IFP Advisors Inc acquired a new position in Iqvia during the fourth quarter valued at approximately $200,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in Iqvia during the fourth quarter valued at approximately $209,000. Finally, Atria Investments LLC acquired a new position in Iqvia during the fourth quarter valued at approximately $218,000. 96.09% of the stock is currently owned by institutional investors and hedge funds.
Shares of Iqvia Holdings Inc (NYSE IQV) opened at $99.78 on Friday. The stock has a market cap of $20,750.00, a P/E ratio of 66.52, a PEG ratio of 1.80 and a beta of 0.61. Iqvia Holdings Inc has a 12 month low of $76.51 and a 12 month high of $110.67. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.22 and a current ratio of 1.19.
IQV has been the topic of a number of recent research reports. TheStreet raised shares of Iqvia from a “c+” rating to a “b” rating in a research report on Wednesday, December 13th. Zacks Investment Research raised shares of Iqvia from a “hold” rating to a “buy” rating and set a $112.00 price target on the stock in a research report on Thursday, January 18th. Stifel Nicolaus raised shares of Iqvia from a “hold” rating to a “buy” rating and lifted their price target for the company from $92.00 to $128.00 in a research report on Friday, October 27th. Royal Bank of Canada set a $118.00 price target on shares of Iqvia and gave the company a “buy” rating in a research report on Thursday, February 15th. Finally, ValuEngine raised shares of Iqvia from a “hold” rating to a “buy” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating, seven have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Iqvia presently has a consensus rating of “Buy” and a consensus price target of $110.02.
In related news, Director John Connaughton sold 1,163,191 shares of Iqvia stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total value of $118,645,482.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of Iqvia stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $102.00, for a total transaction of $764,776,314.00. The disclosure for this sale can be found here. Insiders have sold 8,727,078 shares of company stock worth $890,124,079 in the last quarter. Insiders own 6.40% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Norinchukin Bank The Buys Shares of 17,711 Iqvia Holdings Inc (IQV)” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://stocknewstimes.com/2018/02/24/norinchukin-bank-the-buys-shares-of-17711-iqvia-holdings-inc-iqv.html.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.